Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Sell
17,370
-1,953
-10% -$101K 0.25% 107
2026
Q1
$982K Hold
19,323
0.13% 138
2025
Q4
$570K Sell
19,323
-1,288
-6% -$35K 0.07% 145
2025
Q3
$532K Sell
20,611
-4,286
-17% -$120K 0.06% 141
2025
Q2
$687K Sell
24,897
-2,714
-10% -$71.5K 0.08% 134
2025
Q1
$783K Buy
+27,611
New +$980K 0.09% 141

Other funds holding MRNA

BDF Gestion's MRNA Position: Q2 2026 in Review

BDF Gestion reduced its Moderna (MRNA) stake by 10% in Q2 2026, selling an estimated $101K and leaving 17,370 shares worth $1.86M. The position accounts for 0.25% of the portfolio, ranked #107.

BDF Gestion first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • BDF Gestion held 17,370 shares of Moderna worth $1.86M as of Q2 2026.
  • BDF Gestion sold 1,953 Moderna shares in Q2 2026, an estimated $101K.
  • Moderna made up 0.25% of BDF Gestion's portfolio in Q2 2026, its #107 holding.
  • BDF Gestion first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.